← Leaderboards
Sheida Nabavi
Harvard Medical School
$1,065,756
Attributed
$1,362,838
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $310.3K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,362,838 · 3
By mechanism
R00$596,708 · 1
R01$594,164 · 1
K99$171,966 · 1
Top collaborators
- Clifford Yang2 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Allison Sara Walker$2,097,777
- Anthony Joseph Rosellini$3,050,798
- Haribabu Arthanari$3,796,154
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisMalignant NeoplasmsMalignant Breast NeoplasmAlgorithmsHealth Care CostsClinical DataInnovationBiological MarkersDesignDna RepairBase SequenceBayesian AnalysisConsensusDetectionComputer FrameworkCopy Number PolymorphismCisplatinChemotherapyComparativeBreast Cancer TreatmentBaseCancer CareCancer CenterCancer Therapy
Grant awards (7)
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening$283,847
R01 · FY2025 · CA · contact PI
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening$310,317
R01 · FY2024 · CA · contact PI
Novel integrative method to detect biomakers of breast cancer resistance$194,545
R00 · FY2017 · LM · contact PI
Novel integrative method to detect biomakers of breast cancer resistance$202,054
R00 · FY2016 · LM · contact PI
Novel integrative method to detect biomakers of breast cancer resistance$200,109
R00 · FY2015 · LM · contact PI
Novel integrative method to detect biomakers of breast cancer resistance$89,641
K99 · FY2014 · LM · contact PI
Novel integrative method to detect biomakers of breast cancer resistance$82,325
K99 · FY2013 · LM · contact PI